No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Beam Therapeutics Inc. (NASDAQ:BEAM) Surges 32% Yet Its Low P/S Is No Reason For Excitement
Beam Therapeutics Gains as H.C. Wainwright Starts at Buy
Danaher Posts Upbeat Earnings, Joins Spotify, MSCI, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Express News | Beam Therapeutics Shares Are Trading Higher After HC Wainwright & Co. Initiated Coverage on the Stock With a Buy Rating and Announced an $80 Price Target
Beam Therapeutics Initiated at Buy by HC Wainwright & Co.
Beam Therapeutics Analyst Ratings
No Data